Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Cardiac Hypertrophy

phorbol 12,13-dibutyrate has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imaizumi, T; Kikuchi, T; Koga, A; Miyazaki, H; Ohmura, H; Oka, N1
Oriji, GK1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and Cardiac Hypertrophy

ArticleYear
Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy.
    Journal of cardiovascular pharmacology, 2005, Volume: 45, Issue:3

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Blotting, Northern; Cardiomegaly; Caveolae; Caveolin 3; Caveolins; Cell Size; Cells, Cultured; Immunoblotting; Leucine; Male; Microscopy, Electron; Myocytes, Cardiac; Phorbol 12,13-Dibutyrate; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation

2005
Angiotensin II stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes: roles of PKC and PGF2alpha.
    Prostaglandins, leukotrienes, and essential fatty acids, 2000, Volume: 62, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Fractionation; Cells, Cultured; Dinoprost; Enzyme Activation; Enzyme Inhibitors; Heart Ventricles; Myocardium; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats

2000